A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy

NCT00810953 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Pentamidine

Sponsor

Oncozyme Pharma Inc.